Miranda de Jong1, Anneke Cranendonk2, Mirjam M van Weissenbruch2. 1. Department of Pediatrics, Albert Schweitzer Hospital, Dordrecht, The Netherlands. 2. Department of Pediatrics, Division of Neonatology, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Term small-for-gestational-age (SGA) and preterm born infants have an increased prevalence of metabolic syndrome components already in childhood. Our recent study in 2-y-old very-low-birth-weight (VLBW) infants was limited by the absence of a control group of term born children. We compared the metabolic syndrome components in early childhood in VLBW and term SGA infants to term appropriate for gestational age (AGA) infants. METHODS: We included 38 VLBW children and 82 term born children (64 AGA/18 SGA). HDL cholesterol, triglycerides, glucose, and insulin were measured in blood samples taken at 1 y (term children) and 2 y (all children) of (corrected) age. RESULTS: At 2 y corrected age, VLBW children have lower BMI and higher glucose level compared to AGA children. SGA children have lower BMI at 1 and 2 y of age and a high prevalence of high triglyceride levels at 1 y of age compared to AGA children. Total body fat is a significant determinant of HDL cholesterol and triglycerides and birth weight is a significant determinant of glucose at 2 y corrected age. CONCLUSION: In early childhood, VLBW and term SGA children already have a high prevalence of some metabolic syndrome components compared to term AGA children.
RCT Entities:
BACKGROUND: Term small-for-gestational-age (SGA) and preterm born infants have an increased prevalence of metabolic syndrome components already in childhood. Our recent study in 2-y-old very-low-birth-weight (VLBW) infants was limited by the absence of a control group of term born children. We compared the metabolic syndrome components in early childhood in VLBW and term SGA infants to term appropriate for gestational age (AGA) infants. METHODS: We included 38 VLBW children and 82 term born children (64 AGA/18 SGA). HDL cholesterol, triglycerides, glucose, and insulin were measured in blood samples taken at 1 y (term children) and 2 y (all children) of (corrected) age. RESULTS: At 2 y corrected age, VLBW children have lower BMI and higher glucose level compared to AGA children. SGA children have lower BMI at 1 and 2 y of age and a high prevalence of high triglyceride levels at 1 y of age compared to AGA children. Total body fat is a significant determinant of HDL cholesterol and triglycerides and birth weight is a significant determinant of glucose at 2 y corrected age. CONCLUSION: In early childhood, VLBW and term SGA children already have a high prevalence of some metabolic syndrome components compared to term AGA children.
Authors: A M Fredriks; S van Buuren; R J Burgmeijer; J F Meulmeester; R J Beuker; E Brugman; M J Roede; S P Verloove-Vanhorick; J M Wit Journal: Pediatr Res Date: 2000-03 Impact factor: 3.756
Authors: V Mericq; K K Ong; R Bazaes; V Peña; A Avila; T Salazar; N Soto; G Iñiguez; D B Dunger Journal: Diabetologia Date: 2005-11-08 Impact factor: 10.122
Authors: N J T Arends; V H Boonstra; H J Duivenvoorden; P L Hofman; W S Cutfield; A C S Hokken-Koelega Journal: Clin Endocrinol (Oxf) Date: 2005-01 Impact factor: 3.478
Authors: P L Hofman; W S Cutfield; E M Robinson; R N Bergman; R K Menon; M A Sperling; P D Gluckman Journal: J Clin Endocrinol Metab Date: 1997-02 Impact factor: 5.958
Authors: M L Tjoa; J M G van Vugt; A T J J Go; M A Blankenstein; C B M Oudejans; I J van Wijk Journal: J Reprod Immunol Date: 2003-06 Impact factor: 4.054
Authors: Kathryn Beardsall; Sophie Vanhaesebrouck; Amanda L Ogilvy-Stuart; Christine Vanhole; Christopher R Palmer; Mirjam van Weissenbruch; Paula Midgley; Michael Thompson; Marta Thio; Luc Cornette; Iviano Ossuetta; Isabel Iglesias; Claire Theyskens; Miranda de Jong; Jag S Ahluwalia; Francis de Zegher; David B Dunger Journal: N Engl J Med Date: 2008-10-30 Impact factor: 91.245
Authors: Christine Henriksen; Astrid N Almaas; Ane C Westerberg; Christian A Drevon; Per O Iversen; Britt Nakstad Journal: Eur J Pediatr Date: 2016-08-09 Impact factor: 3.183